U.S., Oct. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07900451) titled 'Multimodal Biomarkers Predicting Medication-Induced Adverse Effects in Children With ADHD' on Oct. 21.
Brief Summary: To build a multimodal model combining neuropsychological, neurophysiological, and metabolomic measures to identify biomarkers predicting MPH-induced adverse effects and their underlying mechanisms, supporting individualized risk assessment in clinical practice.
Study Start Date: Aug. 01
Study Type: OBSERVATIONAL
Condition:
ADHD
Intervention:
DRUG: methylphenidate
The patients with ADHD will receive 16-week treatment with methylphenidate.
Recruitment Status: RECRUITING
Sponsor: National Taiwan University Hosp...